14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
LABU vs NAIL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
LABU Wins Head-to-Head Institutional Verdict (1–0 across 6 Pillars · 3–0 Matrix Metrics)
LABU Overall Winner
6-Pillar Tally: LABU 1 – 0 NAIL (5 Tie)
Matrix Metrics: LABU 3 – 0 NAIL
As of Nov 16, 2026, Direxion Daily S&P Biotech Bull 3X Shares (LABU) is the stronger overall head-to-head candidate over Direxion Daily Homebuilders & Supplies Bull 3X Shares (NAIL) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Options & Positioning). LABU carries a Unified Composite Score of 49.4/100 (HOLD) at $195.22 (N/M Forward P/E, N/A operating margin), whereas NAIL carries 48.8/100 (HOLD) at $32.48 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: LABU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4); meanwhile NAIL is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LABU vs NAIL. Trailing 12-month operating profitability (LABU N/A vs NAIL N/A) and valuation multiples (LABU N/M vs NAIL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
LABU Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
NAIL Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ LABU vs NAIL Key Questions & Quantitative Answers
As of Nov 16, 2026, Direxion Daily S&P Biotech Bull 3X Shares (LABU) is the stronger overall head-to-head candidate over Direxion Daily Homebuilders & Supplies Bull 3X Shares (NAIL) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Options & Positioning). LABU carries a Unified Composite Score of 49.4/100 (HOLD) at $195.22 (N/M Forward P/E, N/A operating margin), whereas NAIL carries 48.8/100 (HOLD) at $32.48 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: LABU is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4); meanwhile NAIL is in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 49.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LABU and NAIL split Growth & Scale metrics: LABU posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NAIL at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, LABU generates N/A in USD-normalized revenue versus N/A for NAIL. In operating R&D and SG&A reinvestment, LABU deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NAIL.
LABU and NAIL trade at balanced relative valuation multiples. LABU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NAIL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LABU (N/A ROE) versus NAIL (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, LABU carries 86.4% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.71β · 119% Vol realized risk). By comparison, NAIL carries 115.4% implied volatility (17th %ile, Compressed (<25th %ile)), a 0.33x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.84β · 137% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.